Table 3 Ability of mesothelin to predict progression- subgroup analysis
From: A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma
Baseline Mesothelin> = 2 | Baseline Mesothelin< 2 | Non-Epithelioid | |
|---|---|---|---|
n | 19 | 24 | 9 |
Progression on CT (Y/N) | 13/6 | 11/13 | 5/4 |
Sensitivity | 100 (75.3–100) | 90.9 (58.7–99.7) | 80.0 (28.4–99.5) |
Specificity | 83.3 (35.9–99.6) | 69.2 (38.5–90.9) | 75.0 (19.4–99.4) |
PPV | 92.7 (68.4–98.7) | 71.4 (51.9–85.2) | 80.0 (40.9–95.9) |
NPV | 100 | 90.0 (57.3–98.4) | 75.0 (32.2–94.9) |